Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study

Abstract The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many proces...

Full description

Bibliographic Details
Main Authors: Sabina Galiniak, Rafał Podgórski, Marta Rachel, Artur Mazur
Format: Article
Language:English
Published: Nature Portfolio 2022-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-21851-8
_version_ 1798028594101878784
author Sabina Galiniak
Rafał Podgórski
Marta Rachel
Artur Mazur
author_facet Sabina Galiniak
Rafał Podgórski
Marta Rachel
Artur Mazur
author_sort Sabina Galiniak
collection DOAJ
description Abstract The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF.
first_indexed 2024-04-11T19:10:33Z
format Article
id doaj.art-391ed9695c4e4e33a865a9c61c864bb0
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T19:10:33Z
publishDate 2022-10-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-391ed9695c4e4e33a865a9c61c864bb02022-12-22T04:07:37ZengNature PortfolioScientific Reports2045-23222022-10-011211810.1038/s41598-022-21851-8Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single studySabina Galiniak0Rafał Podgórski1Marta Rachel2Artur Mazur3Institute of Medical Sciences, Medical College, Rzeszów UniversityInstitute of Medical Sciences, Medical College, Rzeszów UniversityInstitute of Medical Sciences, Medical College, Rzeszów UniversityInstitute of Medical Sciences, Medical College, Rzeszów UniversityAbstract The determination of hormonal biomarkers is of increasing interest in many diseases, including cystic fibrosis (CF). Hormones that have not been estimated and described so far in CF include kisspeptin (KISS) and proopiomelanocortin (POMC), which are involved in the regulation of many processes, including appetite and fertility. Therefore, the aim of our study was to estimate the level of KISS and POMC in sera from CF patients and to determine the correlation between these hormones and clinical parameters. For this purpose, we estimated the levels of KISS and POMC in 38 CF patients and 16 healthy participants with enzyme-linked immunosorbent assay. We found significantly reduced levels of KISS and POMC in people with CF compared to healthy subjects (1.76 ± 0.46 vs. 2.27 ± 0.56 ng/mL, p < 0.05 and 6.25 ± 4.36 vs. 14.74 ± 6.24 ng/mL, p < 0.001, respectively). Furthermore, the level of both hormones was negatively correlated with age. The hormones studied did not correlate with the results of spirometry and each other. Thus, decreased KISS and POMC levels may be associated with lower body weight and delayed puberty in patients with CF.https://doi.org/10.1038/s41598-022-21851-8
spellingShingle Sabina Galiniak
Rafał Podgórski
Marta Rachel
Artur Mazur
Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
Scientific Reports
title Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_full Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_fullStr Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_full_unstemmed Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_short Serum kisspeptin and proopiomelanocortin in cystic fibrosis: a single study
title_sort serum kisspeptin and proopiomelanocortin in cystic fibrosis a single study
url https://doi.org/10.1038/s41598-022-21851-8
work_keys_str_mv AT sabinagaliniak serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy
AT rafałpodgorski serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy
AT martarachel serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy
AT arturmazur serumkisspeptinandproopiomelanocortinincysticfibrosisasinglestudy